𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis

✍ Scribed by Jean-Claude Homberg; Nisen Abuaf; Olivier Bernard; Shamsul Islam; Fernando Alvarez; Samir H. Khalil; Raoul Poupon; François Darnis; Victor-Georges Lévy; Patrick Grippon; Pierre Opolon; Jacques Bernuau; Jean-Pierre Benhamou; Daniel Alagille


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
740 KB
Volume
7
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Sixty-five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity. This disease was found to be rare with a prevalence of 6/1,000,000. The female to male ratio was 8:l. The condition occurred at all ages but was most common between the ages of 2 and 14 years. In 22 of the 65 cases, the hepatitis was associated with an autoimmune disease, most commonly insulin-dependent diabetes, autoimmune thyroid disease and vitiligo. The same autoimmune diseases were present in first-degree relatives from seven families. In 36 cases, the onset of disease resembled acute viral hepatitis. Serum biochemical tests showed marked elevation in aminotransaminases and hypergammaglobulinemia. Paradoxically, serum and salivary IgA levels were often normal or low. Histologic findings were multifocal hepatic necrosis with bridging in the acute stage, and aggressive hepatitis with mononuclear cell infiltration or macronodular cirrhosis in the late stages. Serologically, apart from the presence of antiliver/kidney microsome antibody type 1, the disease was characterized by the absence of antiactin, antimitochondria and antinucleus antibodies; however, organspecific autoantibodies were often present. The clinical course was usually severe: six patients in the acute stage presented with fulminant hepatitis, and all, except two, other patients progressed to cirrhosis, Prolonged treatment with corticosteroids and immunosuppressants was usually effective in rendering the cirrhosis inactive. The cumulative survival rate was 6 1 % at 14 years.


📜 SIMILAR VOLUMES


A genomewide DNA microsatellite associat
✍ Shuichi Yokosawa; Kaname Yoshizawa; Masao Ota; Yoshihiko Katsuyama; Shigeyuki Ka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Genetic predisposition to type 1 autoimmune hepatitis (AIH) is linked mainly to HLA class II genes. We previously searched the whole HLA region for AIH susceptibility genes using microsatellite markers and found only HLA-DR/DQ to be a candidate region for this suspected multifactorial disease. As su

Features associated with treatment failu
✍ Aldo J. Montano-Loza; Herschel A. Carpenter; Albert J. Czaja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Autoimmune hepatitis may fail to respond to corticosteroid therapy, but the frequency and bases for this outcome are uncertain. We aimed to determine the frequency and nature of treatment failure in patients with type 1 autoimmune hepatitis, define features associated with its occurrence, and assess